CD19 and breast cancer: We observed higher percentages and absolute numbers of apoptotic MB-MDA231 cells in the coculture systems in which CD19+ B cells were activated and reduced percentages of apoptotic breast cancer cells in the coculture systems in which the CD19+ B cells were pretreated with sPD-L1.